New pharma and biotech manufacturing facilities and expansions announced worldwide for 2024

[Adobe Stock]

The pharma and biotech sectors continue to rapidly transform in response to rising demand for innovative therapies. While less fortunate players are shedding jobs, in 2024, major players like AbbVie, AGC Biologics, and Amgen are investing heavily in new manufacturing facilities worldwide, from Singapore to Japan and the U.S. Companies expanding in North Carolina, Ohio, and Iceland signal a push to make innovative medicines and advanced therapies more accessible globally.

The map below shows select new plant openings and expansions announced in 2024, with 8 in North America and 15 in other regions

North America United States Amgen opened a new AI-enabled biomanufacturing facility in New Albany, Ohio, employing roughly 400 people. The $365 million investment features automation, AI, and data-driven manufacturing processes. Amgen also plans to advance drug discovery using AI models at deC…
Read more
  • 0

Major pharma players ST Pharm, Astellas and Celltrion unveil ambitious expansion blueprints

[tilialucida/Adobe Stock]

A handful of pharma companies, including ST Pharm, Astellas Pharma, Avalon Pharma, and Celltrion have recently announced expansion projects.

Major pharma expansion efforts underway in South Korea

South Korean CDMO firm ST Pharm announced a second manufacturing facility in its home country — in Ansan, Gyeonggi Province. The plant is geared toward supporting burgeoning demand for oligonucleotide active pharmaceutical ingredients (APIs). The 1.1 trillion won investment speaks to the company’s dedication to advancing the oligonucleotide API sector. The company has supplied nucleoside-API’s for global pharma customers since the 1980s.

Also in South Korea, Celltrion is setting aside 126 million South Korean won for a new manufacturing plant at its Songdo campus near Seoul. Expected to be operational by 2027, this facility will have an annual production capacity of 8 million vials…

Read more
  • 0